Holen Sie sich die Stockscreener-App
1.05
0.00%
0.00
Handel nachbörslich:
1.03
-0.02
-1.90%
Schlusskurs vom Vortag:
$1.05
Offen:
$1.05
24-Stunden-Volumen:
160.28K
Relative Volume:
0.31
Marktkapitalisierung:
$24.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.33M
KGV:
-1.5909
EPS:
-0.66
Netto-Cashflow:
$-13.21M
1W Leistung:
-1.87%
1M Leistung:
-16.00%
6M Leistung:
-7.89%
1J Leistung:
-32.26%
1-Tages-Spanne:
$1.01
$1.05
1-Wochen-Bereich:
$1.01
$1.09
52-Wochen-Spanne:
$0.8101
$2.10
Enlivex Therapeutics Ltd Stock (ENLV) Company Profile
Firmenname
Enlivex Therapeutics Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ENLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
1.05 | 25.05M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.11 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.71 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.17 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
731.77 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.89 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-02 | Bestätigt | H.C. Wainwright | Buy |
Enlivex Therapeutics Ltd Aktie (ENLV) Neueste Nachrichten
Published on: 2025-09-19 05:21:33 - khodrobank.com
Retail Trends: Is now the right time to enter Enlivex Therapeutics LtdMarket Performance Recap & Weekly Momentum Stock Picks - khodrobank.com
Market Overview: How sensitive is Enlivex Therapeutics Ltd to inflation2025 Biggest Moves & AI Forecast Swing Trade Picks - khodrobank.com
Enlivex Announces Positive Phase IIa Results for Allocetra™ in Knee Osteoarthritis - MSN
Custom strategy builders for tracking Enlivex Therapeutics Ltd.July 2025 Fed Impact & Smart Money Movement Tracker - newser.com
Using fundamentals and technicals on Enlivex Therapeutics Ltd.July 2025 Action & Weekly Return Optimization Alerts - newser.com
Applying sector rotation models to Enlivex Therapeutics Ltd.CEO Change & Weekly Return Optimization Alerts - newser.com
Combining machine learning predictions for Enlivex Therapeutics Ltd.Wall Street Watch & Low Risk Entry Point Guides - newser.com
Can machine learning forecast Enlivex Therapeutics Ltd. recoveryWeekly Profit Analysis & Consistent Growth Equity Picks - newser.com
Tick level data insight on Enlivex Therapeutics Ltd. volatilityEarnings Summary Report & Real-Time Sentiment Analysis - newser.com
Using economic indicators to assess Enlivex Therapeutics Ltd. potentialMarket Risk Report & Free High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-09-16 16:43:52 - newser.com
IPO Launch: Is now the right time to enter Enlivex Therapeutics LtdWeekly Risk Report & Weekly Top Performers Watchlists - khodrobank.com
Geopolitics Watch: What dividend growth rate does Enlivex Therapeutics Ltd. offerJuly 2025 Setups & Daily Profit Focused Screening - خودرو بانک
Earnings Report: What analysts say about Enlivex Therapeutics Ltd stockJuly 2025 Drop Watch & Daily Stock Momentum Reports - khodrobank.com
Insider Sell: What analysts say about Enlivex Therapeutics Ltd stockPrice Action & Safe Entry Point Alerts - khodrobank.com
Risk adjusted return profile for Enlivex Therapeutics Ltd. analyzed2025 Institutional Moves & Consistent Growth Stock Picks - newser.com
Enlivex Announces Promising Phase IIa Results for Allocetra in Knee Osteoarthritis - MSN
Sentiment Review: Can Enlivex Therapeutics Ltd reach all time highs this yearQuarterly Trade Summary & Weekly Breakout Opportunity Watchlist - khodrobank.com
H.C. Wainwright reiterates Buy rating on Enlivex Therapeutics stock at $7 - Investing.com India
Growth Recap: Will IBTA be affected by tariffsInflation Watch & Risk Controlled Stock Alerts - خودرو بانک
Value Recap: What is Enlivex Therapeutics Ltd.’s market positionJuly 2025 Breakouts & AI Powered Buy/Sell Recommendations - khodrobank.com
Aug Macro: Can GeoVax Labs Inc. Equity Warrant beat the S&P 500Profit Target & Real-Time Buy Signal Notifications - خودرو بانک
Analyzing Enlivex Therapeutics Ltd. with multi timeframe charts2025 Volatility Report & Long-Term Growth Stock Strategies - newser.com
Is Enlivex Therapeutics Ltd. stock reversal real or fakeGlobal Markets & Risk Controlled Daily Plans - newser.com
Will Enlivex Therapeutics (NASDAQ:ENLV) Spend Its Cash Wisely? - Yahoo Finance
Chart overlay techniques for tracking Enlivex Therapeutics Ltd.Market Sentiment Report & Low Risk Profit Maximizing Plans - newser.com
Enlivex Therapeutics (NASDAQ:ENLV) Earns “Buy” Rating from D. Boral Capital - Defense World
Applying Elliott Wave Theory to Enlivex Therapeutics Ltd.Weekly Trend Recap & Community Trade Idea Sharing Platform - Newser
What technical models suggest about Enlivex Therapeutics Ltd.’s comebackPortfolio Gains Summary & Safe Capital Growth Trade Ideas - Newser
Is Enlivex Therapeutics Ltd. stock entering bullish territory2025 Growth vs Value & Risk Managed Investment Entry Signals - Newser
What data driven models say about Enlivex Therapeutics Ltd.’s futureMarket Volume Summary & AI Driven Stock Movement Reports - Newser
Best data tools to analyze Enlivex Therapeutics Ltd. stockSwing Trade & Reliable Trade Execution Plans - Newser
Can momentum traders help lift Enlivex Therapeutics Ltd.Entry Point & Safe Entry Momentum Stock Tips - Newser
Is this a good reentry point in Enlivex Therapeutics Ltd.2025 Market Trends & Risk Adjusted Swing Trade Ideas - Newser
Price momentum metrics for Enlivex Therapeutics Ltd. explainedEarnings Risk Summary & Reliable Trade Execution Plans - Newser
ENLV Stock: D. Boral Capital Maintains Buy Rating and $13 PT | E - GuruFocus
When is the best time to exit Enlivex Therapeutics Ltd.Weekly Profit Analysis & Free High Accuracy Swing Entry Alerts - Newser
Can technical indicators confirm Enlivex Therapeutics Ltd.’s reversal2025 Market Sentiment & Weekly High Return Opportunities - Newser
Evaluating Enlivex Therapeutics Ltd. with trendline analysisPortfolio Performance Summary & Community Trade Idea Sharing - Newser
Custom watchlist performance reports with Enlivex Therapeutics Ltd.2025 Breakouts & Breakdowns & Reliable Momentum Entry Alerts - Newser
Finanzdaten der Enlivex Therapeutics Ltd-Aktie (ENLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.25%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):